Institute of Immunology and the Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Sciences), School of Life Science and Medical Center, University of Science and Technology of China, Hefei, 230027, China.
Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University Zurich, Zurich, 8091, Switzerland.
Sci China Life Sci. 2017 Dec;60(12):1407-1415. doi: 10.1007/s11427-017-9151-1. Epub 2017 Oct 9.
The lungs, as a place of gas exchange, are continuously exposed to environmental stimuli, such as allergens, microbes, and pollutants. The development of the culture-independent technique for microbiological analysis, such as 16S rRNA sequencing, has uncovered that the lungs are not sterile and, in fact, colonized by diverse communities of microbiota. The function of intestinal microbiota in modulating mucosal homeostasis and defense has been widely studied; however, the potential function of lung microbiota in regulating immunity and homeostasis has just begun. Increasing evidence indicates the relevance of microbiota to lung homeostasis and disease. In this review, we describe the distribution and composition of microbiota in the respiratory system and discuss the potential function of lung microbiota in both health and acute/chronic lung disease. In addition, we also discuss the recent understanding of the gut-lung axis, because several studies have revealed that the immunological interaction among the gut, the lung, and the microbiota was involved in this issue.
肺部作为气体交换的场所,持续暴露于环境刺激物中,如过敏原、微生物和污染物。非培养微生物分析技术(如 16S rRNA 测序)的发展揭示了肺部并非无菌,实际上被多种微生物群落定植。肠道微生物群在调节黏膜稳态和防御方面的功能已得到广泛研究;然而,肺部微生物群在调节免疫和稳态方面的潜在功能才刚刚开始。越来越多的证据表明微生物组与肺稳态和疾病有关。在这篇综述中,我们描述了呼吸系统中微生物组的分布和组成,并讨论了肺部微生物组在健康和急性/慢性肺部疾病中的潜在功能。此外,我们还讨论了最近对肠-肺轴的理解,因为有几项研究表明,肠道、肺部和微生物群之间的免疫相互作用涉及这个问题。